Civeo CORP Schedule 13G passive stakes

American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have collectively disclosed beneficial ownership of over 5% of Civeo Corporation's common stock.

American Century Investment Management has filed a Schedule 13G reporting a 5.1% beneficial ownership stake in Civeo Corporation.

Horizon Kinetics Asset Management LLC has filed an amendment to its Schedule 13G, disclosing a continued beneficial ownership of 21.3% in Civeo Corp's common shares as of December 31, 2025.

Dimensional Fund Advisors LP has reported a 5.5% beneficial ownership stake in Civeo Corp's common stock as of December 31, 2025.

M Partners Fund LP and its affiliates have reported a 0% beneficial ownership in Civeo Corporation, indicating a full divestment or reduction below reporting thresholds.

M Partners Fund LP, along with its general partner and managing member, has reported a 5.31% beneficial ownership stake in Civeo Corporation's common shares.

FMR LLC and Abigail P. Johnson have filed an Amendment No. 12 to their Schedule 13G, reporting a beneficial ownership of 2,200 shares, representing 0.0% of CIVEO CORP's common stock as of February 28, 2025.

Horizon Kinetics Asset Management LLC has filed an amended Schedule 13G, revealing a significant beneficial ownership of 22.3% in Civeo Corp as of December 31, 2024.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, confirming their beneficial ownership of 5.1% of Civeo Corp's common stock as of January 31, 2025.

FMR LLC and its affiliates, including Abigail P. Johnson, have reported a beneficial ownership of 11.2% of Civeo Corp's common stock as of December 31, 2024, through an amended Schedule 13G filing.